A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders.
https://sciencebusiness.technewslit.com/?p=45143
#News #Press #Science #Business #Neuroscience #Neurons #Axons #ALS #NerveDamage #MultipleSclerosis #TraumaticBrainInjury #ClinicalTrial #Therapy #Biotechnology #Chemistry
#News #press #science #business #neuroscience #neurons #axons #als #NerveDamage #multiplesclerosis #traumaticbraininjury #ClinicalTrial #therapy #biotechnology #chemistry